Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccines (Basel)
Hlavní autoři: Narasimhan, Madhusudhanan, Mahimainathan, Lenin, Clark, Andrew E, Usmani, Amena, Cao, Jing, Araj, Ellen, Torres, Fernando, Sarode, Ravi, Kaza, Vaidehi, Lacelle, Chantale, Muthukumar, Alagarraju
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310345/
https://ncbi.nlm.nih.gov/pubmed/34208884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070708
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky